Daily as of 2 Nov 16:00 ET
- Price
- below both $11.76 vs 50 $14.10 / 200 $12.48
- Projection
- ๐Death cross estimated in 16 to 22 bars
- Test
- No active test
- Last cross
- ๐จGolden cross 25 Jun 2026 ยท projected 12 bars out
AngioDynamics (ANGO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jun 2026, but the two have been closing on each other and a death cross is projected within 30 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 20 Oct 2026 | ๐Death | 4-hour | 18 bars out | Not tested |
| 25 Jun 2026 | ๐จGolden moderate | daily | 12 bars out | Not tested |
| 19 May 2026 | ๐จGolden | 4-hour | 16 bars out | Not tested |
| 13 Mar 2026 | ๐Death steep | daily | 12 bars out | 5 bar cross test |
| week of 23 Feb 2026 | ๐จGolden flat | weekly | 17 bars out | 7 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.